Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 85,763

Document Document Title
WO/2014/116754A1
A mutant Bacillus subtilis, which does not express a functional KASIIIA and/or KASIIIB, and method of making; a mutant Rhodospirillum rubrum, which does not express a functional PhaC1, PhaC2, and/or PhaC3, and method of making; method of...  
WO/2014/115816A1
A microorganism having a pathway, said pathway comprising: an enzymatic reaction from glyoxylic acid to glycine; an enzymatic reaction from glycine to serine; and an enzymatic reaction from serine to pyruvic acid or an enzymatic reaction...  
WO/2014/114342A1
There is provided yeast cell walls comprising vitamin D2. The vitamin D may be added vitamin D2 or obtained by treatment of a yeast cells walls fraction with UV light or by treatment of a yeast with UV light followed by autolysis and/or ...  
WO/2014/115934A1
The present invention relates to thesynthesis of a glycerol derivative of a hydroxy fatty acid, and more specifically, to a glycerol derivative of a hydroxy fatty acid prepared by synthesizing 7,10-dihydroxy-8(E)-octadecenoic acid (DOD) ...  
WO/2014/115815A1
An acetyl-CoA-producing microorganism that is obtained by imparting the activity of at least one kind of enzyme selected from the group consisting of malate thiokinase, malyl-CoA lyase, glyoxylate carboligase, 2-hydroxy-3-oxopropionate r...  
WO/2014/115229A1
The present invention relates to a polypeptide which: exhibits binding activity with respect to Fc regions of immunoglobulin G; can be suitably used for the detection, purification, immobilization, or elimination of antibodies, immunoglo...  
WO/2014/117084A3
The present disclosure identifies methods and compositions for modifying photoautotrophic organisms as hosts, such that the organisms efficiently produce alkanes, and in particular the use of such organisms for the commercial production ...  
WO/2014/115430A1
The present invention provides: a humanized anti-HMGB1 antibody that binds specifically to a sequence consisting of an eight-amino-acid residue (EEEDDDDE) at the C terminal of the HMGB1 protein, and that is effective in the treatment or ...  
WO/2014/115924A1
A photobiological culture system of the present invention comprises: a flat-panel type photobiological culture container comprising culture panel bodies coupled to each other in order to provide a culturing space in which photobiological...  
WO/2014/115893A1
The present invention provides: a novel human-derived monoclonal antibody that binds specifically to the F protein of the human metapneumovirus and that neutralizes the human metapneumovirus; an antigen-binding fragment of said antibody;...  
WO/2014/113521A1
The present disclosure provides engineered pNB esterase polypeptides useful for the synthesis of the carbapenem antibiotic, imipenem. The disclosure also provides polynucleotides encoding the engineered pNB esterases, host cells capable ...  
WO/2014/112665A1
The present invention relates to a pharmaceutical composition and a health functional food for preventing or treating steroid-induced diabetes (SID) and, more specifically, to a pharmaceutical composition and a health functional food for...  
WO/2014/113209A1
This invention provides methods and systems for the production of butanol. Specifically, the methods and systems of the present invention use syntrophic co-cultures for the production of butanol from syngas.  
WO/2014/112387A1
The purpose of the invention is to provide a novel antitrypanosomal drug. The invention pertains to actinoallolides (A, B, C, D, and/or E), which are novel compounds produced by the actinomycete MK 10-036; to a method for producing said ...  
WO/2014/110668A1
There is provided a process for growing a phototrophic biomass in a reaction zone, wherein the reaction zone includes a reaction mixture that is operative for effecting photosynthesis upon exposure to photosynthetically active light radi...  
WO/2014/112957A1
For activation and cultivation of production microorganisms producing primary metabolites, and for fermentation of these products with help of such microorganisms, the product, which is produced by the production microorganisms in setup ...  
WO/2014/112574A1
Provided are: a microorganism belonging to the genus Aurantiochytrium, said microorganism having an 18S rRNA gene having a base sequence represented by any of SEQ ID NOS:1-5; Aurantiochytrium sp. OH4 strain; a microorganism which is a va...  
WO/2014/113625A1
This disclosure describes, in one aspect, a composition that includes a transgenic pathogen that expresses a heterologous pathogen associated molecular pattern (PAMP). In some embodiments, the pathogen may be attenuated. In some embodime...  
WO/2014/112666A1
The present invention relates to a method for preparing an extract from the mycelial culture medium of Ceriporia lacerata and a pharmaceutical composition for preventing or treating diabetic diseases and diabetic complications prepared b...  
WO/2014/113208A1
This invention provides compositions for the production of butanol. Specifically, the compositions of the present invention use syntrophic co-cultures for the production of butanol from syngas.  
WO/2014/112627A1
The present invention addresses the problem of providing a series of techniques for producing 1,4-butanediol from methanol or the like. A recombinant cell which is produced by introducing a gene encoding at least one enzyme selected from...  
WO/2014/113541A1
The invention provides vectors, attenuated pathogens, compositions, methods, and kits for use in preventing or treating infection by an infectious pathogen, especially Chlamydia trachomatis. The vectors comprise the plasmid encoded ppg g...  
WO/2014/112637A1
The purpose of the present invention is to make it possible to easily concentrate a metal of a metal-ion-containing solution at a high efficiency and recover the metal from the metal-ion-containing solution at a high recovery efficiency....  
WO/2014/110097A3
Methods and systems for identifying inhibitors of Equilibrative Nucleoside Transporters are provided. Methods and systems for identifying inhibitors of Concentrative Nucleoside Transporters are also provided.  
WO/2014/107953A1
Provided is a C-terminal domain of xylanase XynA originally from a rumen and a method for improving xylanase catalytic efficiency. A new xylanase with high efficiency is provided. The optimum pH of the xylanase in the present invention i...  
WO/2014/108856A1
The present disclosure relates to a comprehensive model for expression of recombinant peptides by Pichia pastoris. The model uses an easily controllable variable called 'critical nutrient ratio' for obtaining a right balance between prod...  
WO/2014/109360A1
Provided is a method which comprises developing a high-expression promoter of Pseudozyma antarctica, constructing a heterologous protein production system with the use of the obtained high-expression promoter, and then efficiently produc...  
WO/2014/108937A1
The present invention provides a novel lactobacillus strain having excellent lactic-acid generating properties and extremely excellent high temperature resistance. This lactobacillus has a high temperature resistance such that the lactob...  
WO/2014/107815A3
A method for high-efficiency genetic transformation of the anaerobic bacterium Clostridium pasteurianum is provided. Clostridium pasteurianum is industrially important due to its selective and high level production of the biofuel and bio...  
WO/2014/109438A1
The present invention relates to a new microalgae Chlorella sp. for accumulating a functional starch and lipid at high concentrations. The cell strain Chlorella sp. ArM29B according to the present invention has been confirmed to be a cel...  
WO/2014/107815A2
By this invention, for the first time, a method for high-efficiency genetic transformation of the anaerobic bacterium Clostridium pasteurianum is provided. Clostridium pasteurianum is a bacterium of substantial industrial importance, due...  
WO/2014/110205A1
The technology described herein relates to siRNAs, e.g., methods and compositions relating to the production of siRNAs in bacterial cells.  
WO/2014/107863A1
Provided are a plant protein and the coding gene and use thereof, in particular provided are a homeotic-leucine zipper protein GhHDbZIP-1 from cotton and the coding gene thereof, and use thereof for cultivating transgenic plants having i...  
WO/2014/107660A2
Disclosed are genetically engineered organisms, such as yeast and bacteria, that have the ability to metabolize atypical nitrogen sources, such as melamine and cyanamide. Fermentation methods using the genetically engineered organisms ar...  
WO/2014/106886A1
Peptide vaccines against cancer are described herein. In particular, isolated epitope peptides derived from the CDCA5 that elicit CTLs and thus are suitable for use in the context of cancer immunotherapy are provided. Further provided ar...  
WO/2014/107660A3
Disclosed are genetically engineered organisms, such as yeast and bacteria, that have the ability to metabolize atypical nitrogen sources, such as melamine and cyanamide. Fermentation methods using the genetically engineered organisms ar...  
WO/2014/107107A2
1. A Streptomyces sp. N02 strain, characterized by a 16S rDNA sequence SEQ No. 1. 2. A method for selecting a strain as claimed in claim 1, characterized in that it comprises the following steps - bringing a sample of the rhizosphere of ...  
WO/2014/106583A1
The present invention relates to a polypeptide binding to human serum albumin and comprising or consisting of an amino acid sequence selected from the group consisting of: (a) GVTLFVALYDY(X1)(X2)(X3)(X4)(X5)(X6)D(X7)SFHKGEKFQIL(X8)(X9)( ...  
WO/2014/107106A1
This invention relates to the use of the Amycolatopsis sp. RC21 strain, of a mutant strain or of an active compound for inhibiting the growth of the causal agent of tuberculosis, and/or inhibiting the proliferation of cancer cells and/or...  
WO/2014/107107A3
1. A Streptomyces sp. N02 strain, characterized by a 16S rDNA sequence SEQ No. 1. 2. A method for selecting a strain as claimed in claim 1, characterized in that it comprises the following steps - bringing a sample of the rhizosphere of ...  
WO/2014/102241A1
The invention relates to a process for identifying gene(s)/genetic element(s) associated with mating impairment in strains of Trichoderma reesei QM6a or strains derived thereof comprising the steps of a) providing a first strain being a ...  
WO/2014/103957A1
The invention provides: an AAV particle containing an adeno-associated viral (AAV) capsid protein having an amino acid sequence selected from the group consisting of SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 24, and SEQ ID NO: 30 of the s...  
WO/2014/104318A1
[Problem] To provide a bacterial cellulose which is highly dispersible in a liquid, shows excellent molding properties and high miscibility with other materials when applied to materials, and, therefore, has a high applicability as a pra...  
WO/2014/104094A1
Provided are avian myeoblastosis virus (AMV) reverse transcriptase with improved heat stability and a method for producing the same. The AMV reverse transcriptase with improved heat stability can be obtained by substituting an amino acid...  
WO/2014/105671A1
The present invention relates to an immunogenic composition comprising: a) one or more antigen of M. hyorhinis and one or more antigens of M. hyosynoviae; and b) a pharmaceutically acceptable carrier. Furthermore, the present invention r...  
WO/2014/101121A1
Disclosed are a zinc finger protein (Czf7)coming from cotton, the encoding gene thereof and use thereof in cultivating of a transgenic plant with improved drought resistance.  
WO/2014/103608A1
A chimeric protein made from a HPV-L2 peptide and an HBs protein, said HPV-L2 peptide being one of the following: (1) a peptide comprising the 20 amino acids of the core sequence region; (2) a peptide comprising part of the core sequence...  
WO/2014/104883A1
The invention is related to a new bacterium comprising a partial 16S rDNA nucleic acid sequence having more than 85% sequence identity to the sequence presented as SEQ ID NO:1, or the complement thereof and a consortium of micro-organism...  
WO/2014/104755A1
The present invention relates to a method for preparing, from wood-based biomass, a high concentration of fermentable sugar which can be effectively used in culturing various industrial fermented bacteria. According to the method of the ...  
WO/2014/102254A1
Process for the production of lipids from biomass including at least one polysaccharide, which comprises fermentation of a biomass hydrolysate using an oleaginous microorganism and separation of oleaginous cellular biomass comprising lip...  

Matches 701 - 750 out of 85,763